SNY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Sanofi's other operating expense for the three months ended in Dec. 2014 was $774 Mil. Its other operating expense for the trailing twelve months (TTM) ended in Dec. 2014 was $3,970 Mil.
Sanofi's quarterly other operating expense declined from Jun. 2014 ($1,154 Mil) to Sep. 2014 ($986 Mil) and declined from Sep. 2014 ($986 Mil) to Dec. 2014 ($774 Mil).
Sanofi's annual other operating expense declined from Dec. 2012 ($6,028 Mil) to Dec. 2013 ($5,263 Mil) and declined from Dec. 2013 ($5,263 Mil) to Dec. 2014 ($3,707 Mil).
GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, Advertising, Research and Development, and Other Operating Expense under the "Total Operating Expenses" section.
Other operating expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of other operating expenses which are simply too numerous to list.
Sanofi Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2014 was 1056.70816044 (Mar. 2014 ) + 1153.5326087 (Jun. 2014 ) + 985.824742268 (Sep. 2014 ) + 774.352651048 (Dec. 2014 ) = $3,970 Mil.
Sanofi Annual Data
|Other Operating Expense||4,623||4,917||5,290||7,220||6,698||7,152||6,626||6,028||5,263||3,707|
Sanofi Quarterly Data
|Other Operating Expense||2,188||1,102||1,633||1,105||1,263||1,057||1,154||986||774||1,152|